| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5898030 | EMD SERONO | hGH containing pharmaceutical compositions |
Apr, 2016
(8 years ago) | |
Serostim is owned by Emd Serono.
Serostim contains Somatropin Recombinant.
Serostim has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Serostim are:
- US5898030
Serostim was authorised for market use on 25 July, 1997.
Serostim is available in injectable;injection dosage forms.
The generics of Serostim are possible to be released after 27 April, 2016.
Drugs and Companies using SOMATROPIN RECOMBINANT ingredient
Market Authorisation Date: 25 July, 1997
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
SEROSTIM family patents
